十一月 2025
- Home
- altona Diagnostics GmbH
十一月 2025的altona Diagnostics GmbH市场份额分析
Highlights altona Diagnostics is the culmination of over 25 years of their innovative achievements. These accomplishments include the first identification of mad cow disease (BSE) in Germany (2000). The team of altona Diagnostics and its predecessor company artus Diagnostics released several of the world’s first commercially available real-time PCR test systems detecting human infectious diseases: […]
altona Diagnostics GmbH(包含公司地区分支机构)
查看更多网站流量和参与度信息- altona-diagnostics.com
altona Diagnostics GmbH收入截至 十一月 2025为 25M - 50M
altona Diagnostics GmbH主要域名产生的收入
3 年中altona Diagnostics GmbH主要域名的收入
altona Diagnostics GmbH主要域名的收入
altona Diagnostics GmbH热门域名的总访问量
了解altona Diagnostics GmbH市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
altona Diagnostics GmbH热门域名的平均访问时长
分析altona Diagnostics GmbH参与度指标。
过去 3 个月的平均访问时长
子公司明细
altona Diagnostics GmbH热门域名的平均页面浏览量
了解altona Diagnostics GmbH如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
altona Diagnostics GmbH 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Diagnostics GmbH launched AltoStar Treponema pallidum PCR Kit 1.5 RUO on Jul 19th '25.altona Diagnostics has recently launched the AltoStar(R) Treponema pallidum PCR Kit 1.5 RUO as a new member of the sexually transmitted infections (STI) panel.
八月 19, 2025阅读更多
新闻Diagnostics GmbH attends event World Vaccine Congress.Longhorn Vaccines and Diagnostics presents compelling data on LHNVD-303 vaccine for sepsis related to bacterial infections at the World Vaccine Congress.
四月 25, 2025阅读更多
新闻GHR Foundation invests into Diagnostics GmbH $15M.ST. LOUIS-(BUSINESS WIRE)-C2N Diagnostics, LLC (C2N), a world leader in developing Alzheimer's disease-specific fluid biomarker tests, has received a new $15 million program-related investment from GHR Foundation (GHR) to support the next generation of tests specific to tau tangle pathology.
九月 30, 2024阅读更多
查看 altona Diagnostics GmbH 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。